Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Jacopo Mariotti, Stefania Bramanti, Raynier Devillier, MD PhD, Barbara Sarina, Sabine Furst, MD, Angela Granata, MD, Valerio Maisano, MD, Thomas Pagliardini, MD, Chiara De Philippis, MD, Catherine Faucher, MD, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Reda Bouabdallah, Armando Santoro, Didier Blaise, MD PhD, Luca Castagna

Blood (2019) 134 (Supplement_1): 4484.

https://doi.org/10.1182/blood-2019-125101

Published: 2019

Journal Articles

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Margaux Damge, Sabine Furst, MD, Bénédicte Devictor, Samia Harbi, MD, Joseph Ciccolini, Angela Granata, MD, Thomas Pagliardini, MD, Boris Calmels, Pharm.D., Claude Lemarie, Pharm.D., Luca Castagna, MD, Valerio Maisano, MD, Faezeh Legrand, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, Evelyne D'Incan, Norbert Vey, MD PhD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2019) 134 (Supplement_1): 4503.

https://doi.org/10.1182/blood-2019-125994

Published: 2019

Journal Articles

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Blood (2019) 134 (Supplement_1): 4614.

https://doi.org/10.1182/blood-2019-128004

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Blood (2019) 134 (Supplement_1): 4625.

https://doi.org/10.1182/blood-2019-131845

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Virginie Lavoipierre, Samia Harbi, MD, Luca Castagna, MD, Angela Granata, MD, Sabine Fürst, MD, Catherine Faucher, MD, Faezeh Legrand, Stefania Bramanti, MD, Christian Chabannon, MD PhD, Norbert Vey, MD PhD, Jérome Rey, Reda Bouabdallah, MD, Jean Marc Schiano De Colella, Djamel Mokart, Pierre-Jean Weiller, Prof., Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2016) 128 (22): 4618.

https://doi.org/10.1182/blood.V128.22.4618.4618

Published: 2016

Journal Articles

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Angela Granata, MD, Sabine Furst, MD, Jean marie Boher, Luca Castagna, MD, Patrice Chevallier, MD PhD, Alice Garnier, MD, Thierry Guillaume, MD PhD, Remy Dulery, MD, Mohamad Mohty, Faezeh Legrand, Samia Harbi, MD, Raynier Devillier, MD PhD, Catherine Faucher, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Boris Calmels, PharmD, PhD, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 4594.

https://doi.org/10.1182/blood.V128.22.4594.4594

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Early Post Transplant Organ Toxicity after Allogeneic One-Haplotype Mismatch (Haplo) Hematopoietic Stem Cell Transplant (HSCT)

Didier Blaise, MD PhD, Clemence Mediavilla, Amir Meskine, Stéfania Bramanti, Samia Harbi, MD, Sabine Furst, MD, Catherine Faucher, MD, Angela Granata, MD, Faezeh Legrand, Djamel Mokart, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Jérome Rey, Diane Coso, Luca Castagna, Raynier Devillier, MD PhD

Blood (2016) 128 (22): 5754.

https://doi.org/10.1182/blood.V128.22.5754.5754

Published: 2016

Journal Articles

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Faezeh Legrand, MD, Valerio Maisano, MD, Sabine Fürst, MD, Angela Granata, MD, Marie Joelle Mozziaconacci, MD, Catherine Faucher, MD, Claude Lemarie, PharmD, Samia Harbi, MD, Christophe Picard, MD PhD, Stephania Bramanti, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Raynier Devillier, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 3417.

https://doi.org/10.1182/blood.V128.22.3417.3417

Published: 2016

Journal Articles

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Raynier Devillier, MD PhD, Hélène Labussière-Wallet, MD, Laurence Clément, MD, Ibrahim Yakoubagha, Jacques-Olivier Bay, MD PhD, Virginie Gandemer, MD PhD, Marie t Rubio, MD PhD, Anne Sirvent, MD, Patrice Chevallier, MD PhD, Thierry Derevel, Sebastien Maury, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2016) 128 (22): 2674.

https://doi.org/10.1182/blood.V128.22.2674.2674

Published: 2016

Journal Articles

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Luca Castagna, MD, Alberto Mussetti, MD, Raynier Devillier, MD PhD, Alida Dominietto, MD, Magda Marcatti, MD, Giuseppe Milone, MD, Francesco Maura, MD, Benedetto Bruno, MD PhD, Sabine Furst, MD, Didier Blaise, MD PhD, Paolo Corradini, MD, Vittorio Montefusco, MD

Blood (2016) 128 (22): 3475.

https://doi.org/10.1182/blood.V128.22.3475.3475

Published: 2016

NARROW

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Early Post Transplant Organ Toxicity after Allogeneic One-Haplotype Mismatch (Haplo) Hematopoietic Stem Cell Transplant (HSCT)

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

A Composite Event-Free Survival End Point to Evaluate Outcome after Allogeneic Transplantation for Severe Aplastic Anemia: A Study on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only